[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 2227 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                S. 2227

To require the Comptroller General of the United States to carry out a 
study on the trafficking into the United States of synthetic drugs, and 
            related illicit finance, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 11, 2023

Mr. Cornyn (for himself and Ms. Cortez Masto) introduced the following 
 bill; which was read twice and referred to the Committee on Banking, 
                       Housing, and Urban Affairs

_______________________________________________________________________

                                 A BILL


 
To require the Comptroller General of the United States to carry out a 
study on the trafficking into the United States of synthetic drugs, and 
            related illicit finance, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preventing the Financing of Illegal 
Synthetic Drugs Act''.

SEC. 2. FINDINGS.

    The Congress finds the following:
            (1) According to the Centers for Disease Control and 
        Prevention, over 107,000 people in the United States died from 
        drug overdoses or drug poisonings in the 12-month period ending 
        January 2022, with 67 percent of those deaths involving 
        synthetic opioids like fentanyl.
            (2) According to the United National Office of Drugs and 
        Crime in its ``Synthetic Drug Strategy 2021-2025'', the number 
        of synthetic drugs, also called new psychoactive substances, 
        has increased 631 percent since 2009, with traffickers 
        introducing an average of 80 new substances to the illicit drug 
        market each year from 2009 to 2019.
            (3) In October 2022, F. Michael McDaniel, director of the 
        Houston High Intensity Drug Trafficking Areas program testified 
        in Congress that 1 kilogram of fentanyl can produce 1,000,000 
        counterfeit pills containing 1 milligram of fentanyl, saying, 
        ``Currently in Houston, Texas, you can buy a kilogram of 
        fentanyl for an average price of $25,000 to $30,000. This same 
        kilogram of fentanyl in Culiacan (Mexico) could be purchased at 
        an average price of $13,500. Currently, the price of a fentanyl 
        pill in Houston ranges from $6 to $65. Therefore, an illicit 
        investment of $30,000 or less could result in a return of $6 to 
        $32.5 million.''.
            (4) According to Celina B. Realuyo, Adjunct Professor, The 
        George Washington University Elliott School of International 
        Affairs, in March 2022 Congressional testimony, ``Financing is 
        essential to support and sustain the command and control, 
        personnel, arms, communications, logistics and operations of 
        organized crime groups. For this reason, following the money 
        trail and depriving criminals of illicit financial flows can 
        disrupt and disable these networks.''.

SEC. 3. GAO STUDY ON SYNTHETIC DRUGS TRAFFICKING.

    (a) Study.--The Comptroller General of the United States shall 
conduct a study on illicit financing in connection with the trafficking 
of synthetic drugs, including fentanyl and methamphetamine, fentanyl- 
and methamphetamine-related substances, Captagon, and fentanyl and 
methamphetamine precursors, that includes--
            (1) the business of the trafficking of synthetic drugs and 
        related illicit finance, such as the participation of 
        transnational criminal organizations and terror syndicates and 
        their notable trafficking corridors, including source and 
        transit countries;
            (2) the business models used by transnational criminal 
        organizations, including United States domestic and foreign 
        activities for precursor purchase or production, movement along 
        the supply chain, manufacture of the completed product, 
        marketing, distribution, sales, and return of proceeds;
            (3) the overlap of the business model of human trafficking 
        and the trafficking of synthetic drugs and related illicit 
        finance;
            (4) the use of online illicit drug markets and the use of 
        social media for the marketing, sale, and payment for synthetic 
        drugs;
            (5) financial methods used by transnational criminal 
        organizations, including--
                    (A) payment;
                    (B) money laundering; and
                    (C) repatriation of proceeds;
            (6) the use of social media applications like Snapchat, 
        Discord, and Facebook and payment applications like Cash App to 
        facilitate financial transactions for synthetic drug 
        trafficking, especially among young people; and
            (7) United States Government activities to combat illicit 
        finance related to the trafficking of synthetic drugs, 
        including--
                    (A) interagency collaboration, such as personnel 
                detailed to other agencies to support the effort to 
                combat synthetic drugs trafficking and related illicit 
                finance;
                    (B) intergovernmental collaboration;
                    (C) intersectoral collaboration with the private 
                sector, including the business and nongovernmental 
                communities; and
                    (D) identified gaps or resource deficiencies in 
                combating the trafficking of synthetic drugs and 
                related illicit finance in the coordination and 
                collaboration activities described in subparagraphs (A) 
                through (C).
    (b) Report.--Not later than 1 year after the date of enactment of 
this Act, the Comptroller General shall submit to Congress a report 
that contains all findings and determinations made in conducting the 
study required under subsection (a).
                                 <all>